GarCitrin®
A widely patented bioavailable composition of natural and synthetic HCA that won Sabinsa its 3rd Thomas Alva Edison Patent Award, the first two were for ForsLean® and Cosmoperine®.
Citrin® range of products comprises salts of HCA with one or more of the following elements - Calcium, Potassium and Magnesium.
As a new addition to the Citrin® range, Sabinsa introduced a more bioavailable form of Citrin® as GarCitrin®.
GarCitrin® is a standardized extract obtained from the dried fruit rinds of Garcinia cambogia and it is standardized for minimum 50% (-) Hydroxycitric acid and minimum 5% Garcinol. More
Latest News
Sabinsa Receives Thomas Alva Edison Patent Award for GarCitrin® Details
Sabinsa Corporation Validates Safety of Garcinia Cambogia Extract in Light of Hydroxycut Warning Details
Obesity - A Global Concern
Obesity is described as a global epidemic and overweight and obese individuals (BMI of 25 and above) are at increased risk for various chronic physical ailments and psychological problems such as depression, eating disorders and low self esteem.
The prevalence of overweight and obesity is increasing throughout the world’s population. The World Health Organization (WHO) reports that more than one billion adults are overweight and at least 300 million of them are clinically obese. WHO considers obesity to be one of the top 10 causes of preventable death worldwide.
The costs involved in the management of obesity and its associated conditions have a significant economic impact on the Global Healthcare System. These conditions also have an indirect impact on the country’s economy by way of decreased productivity, restricted activity, absenteeism, sick days and increased pre-mature mortality.
There is a constant need and search for safe natural approach to help manage obesity and its related socio-economic consequences.